We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04604132
Brief Title: Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma (FIDES-03)

First Submitted : October 21, 2020
First Submitted that Met QC Criteria : October 21, 2020
First Posted : October 27, 2020

Last Update Submitted that Met QC Criteria : February 14, 2023
Last Update Posted : February 16, 2023